 |
recombinant, glycoenfineered humanized IgG1 kappa monoclonal antibody directed against Fibroblast Growth Factor Receptor 2b |
|---|---|
| Trade Name | |
| Orphan Indication | Stomach Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2016-06-29 00:00:00 |
| Sponsor | Five Prime Therapeutics, Inc.;2 Corporate Drive;South San Francisco, California, 94080 |
Related Access Program